Skip to main content

Technology

Room Temperature Aerosol Dehydration (RTAD) technology is a scalable and cGMP-compatible process. RTAD unlocks continuous production of biological therapies as powder and suspension drug formulations

Sub-cutaneous Injections

Dry Powder Inhaler

Nasal Spray And Powder

Microneedle Patch

Cold Chain-free

Ultra-concentrated Suspensions For Sc Administration

Proven rapid ultra-concentration of mAbs and protein drugs to >400 mg/mL in low-viscosity SC injectable formulations

Powdered Drugs With Enhanced Stability And Preserved Biological Activity

Flash dehydration-based formulation process converts liquid biologics into room-temperature-stable drug powders while preserving their biological activity

Scalable Cgmp-compatible Manufacturing

Consistent scale-up parameters, verified by digital twin. Deployable on existing spray-drying infrastructure, enabling 5–10x capacity for inhaled powders

Join us in transforming biologics delivery

Ready to explore collaboration, investment, or new applications of RTAD?